دورية أكاديمية
Network analysis to identify driver genes and combination drugs in brain cancer.
| العنوان: | Network analysis to identify driver genes and combination drugs in brain cancer. |
|---|---|
| المؤلفون: | Roshani F; Department of Physics, Alzahra University, Tehran, Iran. farinaz@alzahra.ac.ir., Ahvar M; Department of Physics, Alzahra University, Tehran, Iran., Ebrahimi A; Department of Physics, Alzahra University, Tehran, Iran. aliebrahimi@ipm.ir.; School of Biological Sciences, Institute for Research in Fundamental Sciences (IPM), Tehran, Iran. aliebrahimi@ipm.ir. |
| المصدر: | Scientific reports [Sci Rep] 2024 Aug 12; Vol. 14 (1), pp. 18666. Date of Electronic Publication: 2024 Aug 12. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: London : Nature Publishing Group, copyright 2011- |
| مواضيع طبية MeSH: | Brain Neoplasms*/genetics , Brain Neoplasms*/drug therapy , Gene Regulatory Networks* , Protein Interaction Maps*/genetics , Protein Interaction Maps*/drug effects, Humans ; Computational Biology/methods ; Gene Expression Regulation, Neoplastic/drug effects ; Antineoplastic Agents/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use |
| مستخلص: | Brain cancer is one of the deadliest diseases, although many efforts have been made to treat it, there is no comprehensive and effective treatment approach yet. In recent years, the use of network-based analysis to identify important biological genes and pathways involved in various complex diseases, including brain cancer, has attracted the attention of researchers. The goal of this manuscript is to perform a comprehensive analysis of the various results presented related to brain cancer. For this purpose, firstly, based on the CORMINE medical database, collected all the genes related to brain cancer with a valid P-value. Then the structural and functional relationships between the above gene sets have been identified based on the STRING database. Next, in the PPI network, hub centrality analysis was performed to determine the proteins that have many connections with other proteins. After the modularization of the network, the module with the most hub vertices is considered as the most relevant module to the formation and progression of brain cancer. Since the driver vertices play an important role in biological systems, the edges of the selected module were oriented, and by analyzing the controllability of complex networks, a set of five proteins with the highest control power has been identified. Finally, based on the drug-gene interaction, a set of drugs effective on each of the driver genes has been obtained, which can potentially be used as new combination drugs. Validation of the hub and driver proteins shows that they are mainly essential proteins in the biological processes related to the various cancers and therefore the drugs that affect them can be considered as new combination therapy. The presented procedure can be used for any other complex disease. (© 2024. The Author(s).) |
| References: | J Mol Cell Biol. 2021 Dec 6;13(9):622-635. (PMID: 34097054) Nature. 2011 May 12;473(7346):167-73. (PMID: 21562557) J Oncol. 2012;2012:723541. (PMID: 22481931) Cancer Med. 2023 Jan;12(1):663-673. (PMID: 35651298) Cancer Discov. 2023 Feb 6;13(2):386-409. (PMID: 36374194) PLoS Comput Biol. 2015 Mar 20;11(3):e1004115. (PMID: 25793737) Trends Mol Med. 2009 Nov;15(11):519-30. (PMID: 19889578) Sci Rep. 2020 Dec 16;10(1):22035. (PMID: 33328499) Brief Bioinform. 2023 Mar 19;24(2):. (PMID: 36847701) Mol Biol Rep. 2023 Mar;50(3):2269-2281. (PMID: 36574092) J Cell Mol Med. 2024 Jun;28(11):e18392. (PMID: 38864705) Sci Rep. 2021 Jul 1;11(1):13668. (PMID: 34211043) Mol Med Rep. 2019 Jul;20(1):539-548. (PMID: 31180548) BMC Cancer. 2017 Aug 11;17(1):539. (PMID: 28800750) Transl Cancer Res. 2021 Jun;10(6):2962-2976. (PMID: 35116604) Proc Natl Acad Sci U S A. 2016 May 3;113(18):4976-81. (PMID: 27091990) Cancers (Basel). 2021 Sep 28;13(19):. (PMID: 34638349) BMC Syst Biol. 2016 Aug 26;10 Suppl 3:65. (PMID: 27585651) Sci Rep. 2024 Jan 26;14(1):2257. (PMID: 38278931) J Biomed Semantics. 2017 Sep 20;8(Suppl 1):27. (PMID: 29297388) Comput Struct Biotechnol J. 2023 Nov 04;21:5446-5450. (PMID: 38022697) Oncol Rep. 2009 Nov;22(5):1149-56. (PMID: 19787233) J Mol Histol. 2004 Mar;35(3):255-62. (PMID: 15339045) Brief Bioinform. 2019 Nov 27;20(6):2253-2266. (PMID: 30239577) J Pers Med. 2022 Jul 28;12(8):. (PMID: 36013184) Nat Rev Cancer. 2010 May;10(5):319-31. (PMID: 20414201) Cell Commun Signal. 2023 Nov 2;21(1):312. (PMID: 37919766) Semin Cancer Biol. 2015 Feb;30:60-9. (PMID: 24657638) Sci Rep. 2012;2:802. (PMID: 23150773) J Clin Med. 2023 Jul 07;12(13):. (PMID: 37445570) Cancer Metastasis Rev. 2010 Dec;29(4):709-22. (PMID: 20839032) Adv Cancer Res. 2014;124:31-82. (PMID: 25287686) Front Oncol. 2022 Apr 06;12:852927. (PMID: 35463300) Genomics. 2020 Nov;112(6):4938-4944. (PMID: 32905831) Semin Cancer Biol. 2013 Aug;23(4):243-51. (PMID: 23712403) Annu Rev Neurosci. 2001;24:385-428. (PMID: 11283316) Sci Rep. 2012;2:218. (PMID: 22355732) |
| فهرسة مساهمة: | Keywords: Brain cancer; Controllability; Driver gene; Hub proteins; Network; Systems biology |
| المشرفين على المادة: | 0 (Antineoplastic Agents) |
| تواريخ الأحداث: | Date Created: 20240812 Date Completed: 20240812 Latest Revision: 20240815 |
| رمز التحديث: | 20240815 |
| مُعرف محوري في PubMed: | PMC11319350 |
| DOI: | 10.1038/s41598-024-69705-9 |
| PMID: | 39134610 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 2045-2322 |
|---|---|
| DOI: | 10.1038/s41598-024-69705-9 |